In a significant advancement in cancer treatment, Thermo Fisher Scientific Inc. (NYSE: TMO) has partnered with the National Cancer Institute (NCI), a component of the National Institutes of Health, to launch the myeloMATCH precision medicine umbrella trial. This initiative aims to revolutionize the treatment landscape for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) through […]
RevBio, Inc., revealed that it has secured a substantial grant of up to $3.4 million, to be disbursed over the next three years, from the National Institute on Aging (NIA), a pivotal segment of the National Institutes of Health (NIH). The grant, provided through the Commercialization Readiness Program, is set to bolster the company’s late-stage […]
Boston Immune Technologies and Therapeutics, Inc. (BITT), a leading clinical-stage biotechnology firm specializing in tumor necrosis factor superfamily receptor (TNFSR) antagonist antibodies, has received a significant financial boost from the National Institutes of Health (NIH). This award aims to advance the preclinical development of BITT’s CD40 antagonist antibody. The NIH funding is a significant step […]
SAB Biotherapeutics said that the US National Institutes of Health (NIH) is discontinuing the phase 3 ACTIV-2 trial of the company’s SAB-185 for the treatment of Covid-19 because of low hospitalization and death rates in the trial. The National Institutes of Health is therefore stopping enrollment in its Covid-19 phase 3 trial, said the US-based […]
Covaxin phase 3 results : Bharat Biotech, an Indian biotech company, said that Covaxin, its whole virion inactivated vaccine against SARS-CoV2, has demonstrated efficacy of 77.8% against symptomatic Covid-19 in phase 3 clinical trials. Efficacy analysis of the Bharat Biotech vaccine showed that it was 93.4% effective against severe symptomatic Covid-19. Against asymptomatic Covid-19, the […]
Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate SPI-1005 in two phase 2 clinical trials from the National Center for Advancing Translational Sciences (NCATS) at the US National Institutes of Health (NIH). SPI-1005 is an oral capsule, which contains a small molecule called ebselen that […]
Cancer Targeted Technology (CTT), a Seattle-based biotech company, has secured a grant of $1.44 million from the US National Institutes of Health (NIH) to support an ongoing clinical trial of a new radiotherapeutic called CTT1403 in prostate cancer. According to the company, the NIH grant has been awarded on the second year of a competitive […]
Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1 clinical trial by eliciting neutralizing antibody titer levels in all eight initial participants across the 25 µg and 100 µg dose cohorts. The early-stage clinical trial in humans was led by the US National Institute of Allergy […]
Coronavirus vaccine trial : US biotech company Moderna has dosed the first participant in the phase 1 study of mRNA-1273, its mRNA vaccine against the novel coronavirus (SARS-CoV-2). The phase 1 coronavirus clinical trial is being carried out under its own Investigational New Drug (IND) application by the National Institutes of Health (NIH). mRNA-1273 is […]